Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

158
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
158
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

104
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
104
Actuarial Approach01:20

Actuarial Approach

64
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
64
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

107
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
107
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

189
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
189
  1. Home
  3. Factors Influencing Outcomes And Survival In Anal Cancer.
  1. Home
  3. Factors Influencing Outcomes And Survival In Anal Cancer.

Related Experiment Video

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

Factors Influencing Outcomes and Survival in Anal Cancer.

Hugo C Temperley1,2,3, Benjamin M Mac Curtain2, Niall J O'Sullivan1,2

  • 1Department of Radiology, St. James's Hospital, D08 NHY1 Dublin, Ireland.

Current Oncology (Toronto, Ont.)
|September 27, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Stage, nodal status, and tumor differentiation are key prognostic factors for anal cancer patients. Identifying these indicators aids in managing anal malignancy and predicting patient outcomes.

Keywords:
anal canceroncological outcomesrecurrencesalvage surgerysurvivaltreatment response

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.5K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.5K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Anal cancer management and outcomes require identification of prognostic factors.
  • Understanding these factors is crucial for current treatment strategies.

Purpose of the Study:

  • To ascertain prognostic factors in the current management of anal cancer.
  • To assess demographic characteristics, clinical presentation, and outcomes of anal cancer patients.

Main Methods:

  • Retrospective review of anal cancer cases (2016-2023).
  • Kaplan-Meier survival analysis and log-rank testing for survival differences.
  • Cox proportional hazards regression to identify prognostic factors.

Main Results:

  • 75 anal cancer patients included; 88% squamous cell carcinoma (SCC).
  • Adverse prognostic indicators: T4 disease (HR=3.81), poorly differentiated tumors (HR=3.37), N2 nodal status (HR=5.03), and metastatic disease (HR=5.8).
  • 84% received definitive chemoradiation (dCRT); 11.1% required salvage surgery.

    • Conclusions:

    • Presenting characteristics including stage, nodal, and differentiation status remain key prognostic indicators.
    • These factors are critical for predicting outcomes in anal malignancy.